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Abstract: The pseudotype particle neutralization test (pp-NT) is a next-generation serological assay
employed for the sensitive study of influenza antibody responses against hemagglutinin (HA),
including stalk-directed antibodies. However, a validation of this assay has yet to be performed,
and this limits its use to primarily research laboratories. To identify possible serological standards
to be used in optimization and validation of the pp-NT, we have evaluated the cross-reactivity of
hyperimmune chicken reference antisera in this assay. Our findings show that the cross-reactivity
detected by the pp-NT is only partly explained by phylogenetic relationships and protein homology
between the HA subtypes analysed; further studies are necessary to understand the origin of the
cross-reactivity detected, and reference standards with higher specificity should be evaluated or
generated de novo for future use in pp-NT.
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1. Introduction
Serological methods such as single radial haemolysis (SRH), haemagglutination inhibition (HI)
and microneutralization (MN) are cost-effective and widely-used methodologies to monitor the
circulation and prevalence of influenza viruses, and are also employed in vaccine immunogenicity
studies [1]. However, these assays have numerous shortcomings, especially related to the variability of
the reagents, their standardization between laboratories, and their ability to detect haemagglutinin
(HA) stalk-directed antibodies. Enzyme-linked immunosorbent assays (ELISAs) are used to detect
stalk-directed antibodies, but are unable to differentiate between binding and neutralizing antibodies.
Recently, the use of replication-deficient viruses in neutralization assays has been widely evaluated
as a potential alternative to MN assays. For example, HA pseudotype particles (pp) harbouring the
HA embedded in the viral envelope and having a lentiviral vector as backbone have been used
effectively for this purpose [2,3]. The pseudotype particle neutralization test (pp-NT) appears to
be more sensitive than other functional assays in the detection of the antibody response directed
against the HA stalk [4]. Consequently, pp could be used to effectively study heterosubtypic antibody
responses directed against the HA stalk region. Importantly, pp-NTs have been shown to correlate
strongly with other classical serological assays [5–8]. Since pp are replication-defective, they offer a safe
alternative to wild-type virus methods (that require Biosafety Level 3 containment), and the detection
of antibody responses is not influenced by the variability of blood-based reagents as observed in other
assays (i.e., red blood cells in HI). Unfortunately, the validation of pp-NT, which will permit its more
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extensive use in surveillance as well as in pre-clinical and clinical studies, has not yet been established.
The validation of pp-NT will allow the certification of its use in product release and stability control (if,
in the future, HA stalk-directed monoclonal antibodies will be licensed) and in evaluating antibody
responses elicited by current and “next-generation universal” influenza vaccines.
The availability of appropriate reference materials is essential for the optimization and validation
of an assay. Appropriate reference standards are especially useful when the specificity, sensitivity,
precision, and accuracy of an assay are evaluated for the first time [9], but are also essential when
other assay parameters (e.g., dilution range or calibration curves) are established [10]. Furthermore,
reference standards have an essential role in monitoring assay stability and consistency over different
analytical sessions (e.g., days) [11]. Reference materials are also useful when multisite validation of an
assay is performed. For example, the use of reference standard sera has been shown to be extremely
useful to increase consistency between laboratories using HI and SRH [12]. Chicken reference antisera
against all the HA subtypes are commonly generated and used for influenza virus typing in the HI
assay [13,14], and thus should be investigated as possible controls and reference materials in pp-NTs,
which was the purpose of this study.
2. Results and Discussion
We have evaluated the neutralization activity and cross-reactivity of chicken reference antisera
against a panel of pp bearing HAs of a representative strain (where possible of avian origin), for each
HA subtype. Unfortunately, H6 and H13 influenza pp were not used in this study since appropriate
pp bearing the HA of these two subtypes were not available.
The neutralizing titres resulting after analysis with GraphPad Prism software were elaborated
using Microsoft Excel and the statistical software R to generate a “heat map” (Figure 1). Phylogenetic
analysis was also used to highlight relationships between HA subtypes. Observing Figure 1, some
features of the cross-reactivity map become immediately discernible: in the top left, there are Group
1 HA pp against Group 1 reference antisera, in the bottom right there are Group 2 HA pp against
Group 2 reference antisera, and in the bottom left and top right there are the results of pp tested with
reference antisera from a different group. The cross-reactivity map diagonal represents pp that were
tested against matching antisera, and as expected, the higher neutralization titres are usually found
in this part of the table. It can also be noticed that two map-shifts are present, since the H6pp and
H13pp are missing. A clear symmetry can be visualised using the diagonal as symmetry axis, and
in general, high neutralization titres are found when pp are tested with antisera of the same group
(top left and bottom right). Conversely, sometimes antisera neutralize pp that harbour HAs of a
completely different subtype/group. Other important features are that pp were usually neutralized
by antisera generated against closely related viruses: in fact, using the two phylogenetic trees as
guides, it is possible to identify clusters of darker green in relation to phylogenetic clades; for example,
the H2-H5, H12-H8-H9, H11-H16-H13, H4-H14, and H7-H15. The cross-reactivity heat map shows
that influenza reference antisera are usually able to efficiently neutralize HA-matched pp, and minor
variation in the neutralizing titres can be observed when the serum was generated against paired
(same subtype but different strain) HAs. Additionally, cross-reactive responses can be detected not
only when phylogenetic relationships are present between the HA of the pp tested and the HA used as
antigens to generate the antisera, but also between HA and antisera that share less similarity (Figure 1).
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Figure 1. Cross-reactivity map of pseudotype particles (pp) and reference sera based on IC50. The IC50 
values used for the cross-reactivity heat map were the result of arithmetic means between one or more 
different experiments performed when the same batch of sera and the same batch of pp were 
available, in order to minimize potential additional variability factors. Note: H7N7 (1) is 
A/turkey/England/647/1977 (H7N7) and H7N7 (2) is A/England/268/1996 (H7N7). 
Looking at Figure 1, distinctive cross-reactivities can be observed. H1pp was highly neutralized 
by the matched antisera, but not by antisera generated against closely related HAs (H2/H5); however, 
it was neutralized by other Group 1 antisera (H8N4 and H11N9) and additionally by three Group 2 
antisera. The H2pp and H5pp were neutralized by each other’s antisera, by the antisera generated 
against the most closely related HAs (H1 and H6), but also by H8N4, H9N2, and H11N9 antisera. 
Even though closely related, H8pp and H12pp did not exhibit neutralization by each other’s antisera; 
however, they were neutralized by the antisera generated against the closely related H9N2. 
Furthermore, H8pp was also neutralized by the antisera generated against H1-H2-H5, and by some 
antisera of Group 2, especially the ones generated against H7 viruses. All the antisera, without 
distinction of HA subtype, neutralized H9pp: higher neutralization activities were detected for 
Group 1 antisera, for H14N5 and H7 antisera, especially anti-H7N7. H11pp and H16pp were 
neutralized by their matched antisera and by antisera generated against other closely related HA, 
and by H1N1 antisera. For H16pp, neutralization activity was also detected when H12N5, H8N4, and 
H7 antisera were used. For Group 2 pp, A/Udorn/207/1972 H3pp (a human isolate) was poorly 
neutralized by the matched avian antisera, but was neutralized by the anti-H7N2 sera, one of the 
H7N7 antisera, and by numerous Group 1 antisera. H4pp was neutralized by all Group 2 antisera 
and by the H9N2 antisera. H14pp was neutralized by the matching antisera and by the antisera 
generated against the closely related H4. H7pp and H15pp were neutralized by their matched 
antisera and by each other’s antisera; Group 1 sera were also found to cross-react with H15pp and 
some (H6N2 and H13N9) also with H7pp. H10pp was only neutralized by its matching antisera and 
not by any others. 
Many studies have previously observed that chicken antisera generated using whole virus 
present a lower specificity in HI and/or immunodot-blot assays in comparison to the ones generated 
through HA-expressing DNA vaccination or recombinant HA1 vaccination [15,16]. However, since a 
certain level of cross-reactivity is also observed with DNA or recombinant protein vaccination, cross-
reactive HA-directed antibodies are likely involved [16].  
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Figure 1. Cross-reactivity map of pseudotype particles (pp) and reference sera based on IC50. The IC50
values used for the cross-reactivity heat map were the result of arithmetic means between one or
more different experiments performed when the same batch of sera and the same batch of pp
were available, in order to minimize potential additional variability factors. Note: H7N7 (1) is
A/turkey/England/647/1977 (H7N7) and H7N7 (2) is A/England/268/1996 (H7N7).
Looking at Figure 1, distinctive cross-reactivities can be observed. H1pp was highly neutralized
by the matched antisera, but not by antisera generated against closely related HAs (H2/H5); however,
it was neutralized by other Group 1 antisera (H8N4 and H11N9) and additionally by three Group 2
antisera. The H2pp and H5pp were neutralized by each other’s antisera, by the antisera generated
against the most closely related HAs (H1 and H6), but also by H8N4, H9N2, and H11N9 antisera.
Even though closely related, H8pp and H12pp did not exhibit neutralization by each other’s
antisera; however, they w re neutralized by the an isera generated against the closely related H9N2.
Furthermore, H8pp was also neutralized by the antisera generated against H1-H2-H5, and by some
antisera of Group 2, especially the ones generated against H7 viruses. All the antisera, without
distinction of HA subtype, neutralized H9pp: higher neutralization activities were detected for Group
1 antisera, for H14N5 and H7 antisera, especially anti-H7N7. H11pp and H16pp were neutralized
by their matched antisera and by antisera generated against other closely related HA, and by H1N1
antisera. For H16pp, neutralization activity was also detected when H12N5, H8N4, and H7 antisera
were used. For Group 2 pp, A/Udorn/207/1972 H3pp (a hu an isolate) was poorly neutralized by
the matched avian antisera, but was neutralized by the anti-H7N2 sera, on of the H7N7 antisera,
and by umerous Group 1 anti era. H4pp was neutraliz d by all Group 2 antisera and by the H9N2
antisera. H14pp was neutralized by the matching antisera a d by the antisera generated against the
closely related H4. H7pp and H15pp were neutralized by their matched antisera and by each other’s
antisera; Group 1 sera were also found to cross-react with H15pp and some (H6N2 and H13N9) also
with H7pp. H10pp was only neutralized by its matching antisera and not by any others.
Many studies have previously observed that chicken antisera generated using whole virus present
a lower specificity in HI and/or immunodot-blot assays in comparison to the ones generated through
HA-expressing DNA vaccination or recombinant HA1 vaccination [15,16]. However, since a certain
level of cross-reactivity is also observed with DNA or recombinant protein vaccination, cross-reactive
HA-directed antibodies are likely involved [16].
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In this study, commonly used reference antisera (for haemagglutination inhibition assay, agar
gel immunodiffusion test, and agar gel precipitation test) show high neutralizing responses and
cross-reactivity between different strains/subtypes. This could be problematic not only for HI typing,
but especially for pp-NT. In fact, in the dilution range analysed, the pp-NT could not discriminate
between two distinct pp (e.g., H16 pp was neutralized at the same dilution tested by both H16N3 and
H13N6 sera). Preparation of the standard material through dilution of the commonly used reference
standard or the use of monoclonal antibody mixtures (with or without the presence of a serum matrix)
showing high specificity could be more effective approaches to establish reference materials to be used
to validate, standardise, and control pp-NTs. To better understand which factors are underlying the
observed cross-reactivity, we have evaluated the percentage amino acid identity between the HAs
present on the pp and the HAs used for antisera generation. A percentage-identity heat map was then
produced (Figure 2).
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Figure 2. Cross-reactivity map of pp and reference sera based on percentage of amino acid
identity. Percentage identities between haemagglutinin (HA) amino acid sequences trimmed of their
N-terminal signal, the transmembrane region, and the cytoplasmic tail were calculated by pair-wise
alignments using Jalview and coloured using the heatmap function in R. In the figure, H7N7 (1) is
A/turkey/England/647/1977 (H7N7) and H7N7 (2) is A/England/268/1996 (H7N7).
This map shows a similar overall pattern to the cross-re ctivity map (Figure 1). There is a
symmet y following the diagonal, the darker green is c ncentrated in the top left and bottom right
sector of the map. However, compared to the previous m p (Figur 1), dark green cannot be observed
in th two other sectors of the maps; thus, as expe ted, t e similarity between strains belonging to
different groups is low. Since it is difficult to hig light all the differences and similarities by eye,
statistical analysis was performed to see whet er any concordance or association between the maps
was present. Kendall τ test shows that there is low association between percentage identity and
neutralization titres (τ = 0.225, p = 2.38 × 10−7). This means that the percentage amino acid identity
is a good approach to evaluate the cross-reactivity response, but other approaches should be used
to understand and explain the cross-reactivity detected. Antigenic cartography has recently been
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used to evaluate the antigenic evolution/drift of different influenza viruses and to help vaccine
strain selection [17,18]. This methodology could be used to analyse the data presented here, and
should permit a representation of the antigenic interplay between different pp. In the absence of
appropriate controls and the presence of high cross-reactivity responses, it will be difficult to assess the
specificity of the pp-NT assay. Other parameters should be evaluated to understand if factors unrelated
with the sera antibody content could interfere with the pp-NT assay. For example, the presence of
virus-attachment inhibitors in the sera and serum treatments (e.g., heat-inactivation, pre-treatment
with receptor-destroying enzymes) and/or the presence and type of adjuvant used can be assessed to
optimise pp-NT assay conditions and to reduce non-specific neutralization if present. Additionally,
the evaluation of possible haemolysis or other contaminants (e.g., lipids) of the serum samples is a
factor that needs to be taken into consideration when the assay is optimised and validated [9].
3. Materials and Methods
3.1. Reference Sera
The avian reference hyperimmune sera used for these studies and associated HI titres were
provided by Dr. Giovanni Cattoli when he was at the Istituto Zooprofilattico delle Venezie (IZSVe),
World Organization for Animal Health (OIE), Legnaro, Padua, Italy, and are reported in Table 1.
Table 1. IZSVe avian influenza reference antisera for haemagglutination inhibition assay, agar gel
immunodiffusion test, and agar gel precipitation test.
Antigen Strain Name Subtype HA Accession Number HI Titre
A/duck/Italy/1447/2005 H1N1 HF563054.1 1:512
A/duck/Germany/1215/1973 H2N3 CY014710.1 1:512
A/psittacine/Italy/2873/2000 H3N8 GQ247846.1 * 1:256
A/cockatoo/England/1972 H4N8 GQ247847.1 * 1:128
A/turkey/Canada/1965 H6N2 GQ247851.1 * 1:256
A/turkey/Ontario/6118/1968 H8N4 CY014659.1 1:512
A/mallard/Italy/3817-34/2005 H9N2 Not Applicable 1:256
A/ostrich/South Africa/2001 H10N1 GQ247860.1 * 1:512
A/duck/Memphis/546/1974 H11N9 AB292779.1 1:1024
A/duck/Alberta/60/1976 H12N5 CY130078.1 1:128
A/gull/Maryland/704/1977 H13N6 D90308.1 1:1024
A/mallard/Gurjev/263/1982 H14N5 M35997 1:512
A/shearwater/Australia/2576/1979 ** H15N9 CY130102.1 1:2048
A/gull/Denmark/68110/2002 H16N3 GQ247872.1 * 1:256
* Partial sequence; ** Also known as A/shearwater/West Australia/2576/1979.
Reference avian sera against H5 and H7 influenza strains were provided by the Animal and
Plant Health Agency (APHA, previously Animal Health and Veterinary Laboratories Agency) and are
reported in Table 2.
Table 2. Animal and Plant Health Agency (APHA) avian influenza reference antisera.
Antigen Strain Name Subtype HA Accession Number HI Titre
A/chicken/Scotland/1959 H5N1 CY015081.1 Not available
A/African starling/England/983/1979 H7N1 AF202232.1 Not available
A/chicken/Wales/1306/2007 H7N2 EF675618.1 Not available
A/chicken/England/4054/2006 H7N3 EF467826.1 Not available
A/England/268/1996 H7N7 AF028020.1 Not available
A/turkey/England/647/1977 H7N7 AF202247.1 Not available
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Sera were produced by inoculation of specific pathogen-free chickens with whole influenza
viruses, in accordance with OIE guidelines (World Organization for Animal Health). If necessary,
sera were pre-adsorbed with chicken red blood cells (RBCs). Other pre-treatments (e.g., decomplementation
at 56 ◦C for 30 min, treatment with receptor-destroying enzymes) were not performed.
3.2. Pseudotype Particles and Pseudotype Particle Neutralization Assays
Lentiviral pseudotyped particles were produced as described previously [8,19]. Briefly, the
HIV gag-pol plasmid p8.91, the firefly luciferase-expressing plasmid pCSFLW, the HA-expressing
plasmid (Table 3), and the pCAGGS-TMPRSS2 or HAT were co-transfected into human embryonic
kidney HEK293T/17 cells using Polyethylenimine (PEI). After 24 h incubation, 1 U of recombinant
neuraminidase from Clostridium perfringens (Sigma) was added to facilitate pseudotype exit from the
producer cells. Supernatant was harvested forty-eight hours post-transfection, filtered through 0.45 µm
filters, and stored at −80 ◦C.
Table 3. Haemagglutinin-encoding plasmids used for pseudotype production.
Plasmid Backbone HA HA Accession Number
pI.18 A/duck/Italy/1447/2005 H1 HF563054.1
pI.18 A/Korea/426/1968 H2 CY125846.1
phCMV1 A/duck/Germany/1215/1973 H2 CY014710.1
pI.18 A/Udorn/307/1972 H3 DQ508929.1
phCMV1 A/duck/Czechoslovakia/1956 H4 D90302.1
pI.18 A/Vietnam/1194/2004 H5 ABP51976.1
pI.18 A/chicken/Italy/1082/1999 H7 ABR37396.1
phCMV1 A/turkey/Ontario/6118/1968 H8 CY014659.1
pI.18 A/Hong Kong/1073/1999 H9 AJ404626.1
phCMV1 A/chicken/Germany/N49 H10 CY014671.1
phCMV1 A/duck/Memphis/546/1974 H11 AB292779.1
phCMV1 A/duck/Alberta/60/1976 H12 CY130078.1
phCMV1 A/gull/Maryland/704/1977 H13 D90308.1
phCMV1 A/mallard/Astrakhan/263/1982 H14 AB289335.1
phCMV1 A/shearwater/West Australia/2576/1979 H15 CY130102.1
phCMV1 A/black-headed gull/Sweden/2/1999 H16 AY684888.1
The pp-NTs were performed as described elsewhere [19], using 5 µL of each serum sample
(starting dilution 1:40) and using a pp input of 1 × 106 RLU/well. IC50 neutralization titres were
calculated using GraphPad Prism® expressed as dilution factor; then for further statistical analysis,
they were categorised into 17 groups according to the dilution tested and as reported in Table 4.
Table 4. Categories of IC50 values used for statistics.
Group IC50 Values Dilution Factor
0 <35 <40
1 35–45 40
2 45–75 40–80
3 75–85 80
4 85–150 80–160
5 150–170 160
6 170–310 160–320
7 310–330 320
8 330–630 320–640
9 630–670 640
10 670–1270 640–1280
11 1270–1290 1280
12 1290–2550 1280–2560
13 2550–2570 2560
14 2570–5100 2560–5120
15 5100–5140 5120
16 >5140 >5120
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A cross-reactivity map (pp versus reference antisera) completed using the neutralization groups
for further statistical analysis, was designed in a Microsoft® Excel 2011 spread sheet and then saved as
a comma-separated values (csv) file.
3.3. Bioinformatic Analysis
Percentage identity between HA amino acid sequences of pp and reference sera antigens were
calculated to check if cross-reactivity could be explained by overall sequence similarity. Amino acid
sequences of the HA used in neutralization assays, and used to generate the reference antisera, were
downloaded from the Influenza Virus Resource, the Influenza Research database, and the Global
Initiative on Sharing Avian Influenza Data (GISAID) EpiFlu™ platform [20]. The accession numbers
of the HAs used in pp-NT assays are reported in Table 3; HA accession numbers of the reference
antisera are reported in Tables 1 and 2. For A/mallard/Italy/3817-34/2005 (H9N2), the HA sequence
was not available at the time of analysis, and therefore the pp sequence was used as a reference.
Additionally, some of the HA sequences in the databases were incomplete, which complicates the
analysis. To minimize this, it was decided to evaluate the percentage identity only for the amino acids
that constitute the extracellular part of the HA (amino acids from 24 to 547 using H3 numbering),
which were available for all HAs used. All sequences were aligned using MUSCLE algorithm [21]
and Jalview software [22]. Subsequently, the sequences were trimmed of their N-terminal signal
sequence, the transmembrane region, and the cytoplasmic tail. Percentage identities between amino
acid sequences were calculated by pair-wise alignments using Jalview before being reported in a
Microsoft® Excel 2011 spreadsheet and saved as a csv file. The phylogenetic trees shown alongside
the cross-reactivity and the percentage identity tables were generated using Molecular Evolutionary
Genetics Analysis (MEGA) software [23]: the aligned sequences were imported and trees derived
using Unweighted Pair Group Method with Arithmetic mean (UPGMA), the simplest method of tree
construction based on pairwise evolutionary distances. The trees generated were manually modified
using MEGA and FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
3.4. Statistical Analysis
Cross-reactivity tables for the IC50 neutralization titres, expressed as group, and for percentage
amino acid identity, were completed using Microsoft® Excel 2011. R statistical software was then
used to analyse the data and design a “heat-map” which colour codes the neutralization titres and the
percentage identity. These codes are based on the use of the software package “RColorBrewer”(which
permits a personalised colour palette to be built), and “gplots”, a package that contains functions for
the graphical interface. The “heatmap.2” function was eventually used to assign a colour to each IC50
group or percentage identity value. Kendall τ (tau) statistics (“Kendall” package) was also run using
R software to check if association/correlation between measured IC50 titres and percentage identity
was present.
4. Conclusions
To conclude, the results presented here show that the high sensitivity and the propensity of the
pp-NT assay to detect cross-reactive responses does not permit the use of current chicken reference
standard antisera as reference materials to validate the assay. Until more appropriate standards
(e.g., ferret sera or monoclonal antibody mixtures) are developed to further progress optimisation
and validation of the pp-NT assay, the routinely used reference standards should be used as positive
neutralization controls only in experimental research settings.
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